Search

everythinglearnresearchcommunity

for

Search:↓

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Hydroxychloroquine may help delay skin damage in lupus patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Model improves accuracy in predicting hair loss effects.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Early balding linked to higher heart disease risk.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Minoxidil helps some bald men, but most lose hair again when stopping.

Most people using minoxidil for hair loss probably won't see significant improvement.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Using minoxidil on balding scalps can stimulate hair regrowth and increase blood flow. It's an effective treatment for early hair loss.